Area of research
Materials Chemistry · Cancer Research
Research interest
Research focused on Cancer research and Ovarian cancer, with related work in Breast cancer, Triptolide, Nucleolin. Notable publications include 'A potential prognostic long non-coding RNA signature to predict metastasis-free survival of breast cancer patients', 'Triptolide inhibits viability and induces apoptosis in liver cancer cells through activation of the tumor suppressor gene p53', and 'Engineered antibody CH2 domains binding to nucleolin: Isolation, characterization and improvement of aggregation'.
SLC7A5-ERBB2 axis drives olaparib resistance via de novo lipid synthesis in ovarian cancer
ZNF146 regulates cell cycle progression via TFDP1 and DEPDC1B in ovarian cancer cells
Knockdown of TRIM44 inhibits the progression of ovarian cancer and is related to the FOXM1-EZH2 signaling pathway
Triptolide inhibits viability and induces apoptosis in liver cancer cells through activation of the tumor suppressor gene p53
Engineered antibody CH2 domains binding to nucleolin: Isolation, characterization and improvement of aggregation
A potential prognostic long non-coding RNA signature to predict metastasis-free survival of breast cancer patients